Analyst Consensus ?
ConsensusHold37 ratings
Bullish2156.8%
Neutral1437.8%
Bearish25.4%
FN2 Earnings Intelligence
Corning Inc (GLW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Oct 21, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 6, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 29, 2025 |
| HSBC | Buy | Hold | Upgrade | Jan 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 30, 2024 |
| Fox Advisors | Overweight | Equal Weight | Upgrade | Jun 17, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 27, 2022 |
| Cross Research | Neutral | Buy | Downgrade | Sep 17, 2019 |
| Bank of America | Buy | Neutral | Upgrade | May 1, 2019 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 1, 2017 |
| Guggenheim | Buy | Buy | Maintain | Jan 4, 2017 |
| Wells Fargo | Perform | Market Perform | Maintain | Dec 21, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Jun 13, 2016 |
| Drexel Hamilton | Sell | Buy | Downgrade | Jun 10, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 28, 2015 |
| Benchmark | Hold | Hold | Maintain | Jul 29, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 16, 2015 |
| CLSA | Sell | Underperform | Maintain | Apr 29, 2015 |
| Jefferies | Hold | Hold | Maintain | Feb 2, 2015 |
| Standpoint | Buy | Hold | Upgrade | Oct 15, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Oct 23, 2013 |
| Stifel | Buy | Buy | Maintain | Oct 23, 2013 |
| Sterne Agee | Neutral | Buy | Downgrade | Oct 23, 2013 |
| PiperJaffray | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Piper Sandler | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Gilford Securities | Buy | Buy | Maintain | Sep 23, 2013 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Sep 19, 2013 |
| Topeka | Buy | Buy | Maintain | Nov 27, 2012 |
Upside is calculated against the persisted previous close $127.74. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $201 | $164.16 | +57.4% | Oct 5, 2026 |
| Bernstein | Daniel Zhu | $140 | $158.75 | +9.6% | Sep 30, 2026 |
| Mizuho Securities | John Roberts | $180 | $143.5 | +40.9% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $175 | $138.25 | +37.0% | Aug 2, 2026 |
| Morgan Stanley | Analyst unavailable | $165 | $125.88 | +29.2% | Jul 29, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $125.88 | +64.4% | Jul 29, 2026 |
| UBS | Joshua Spector | $196 | $125.88 | +53.4% | Jul 29, 2026 |
| Oppenheimer | Analyst unavailable | $200 | $125.88 | +56.6% | Jul 29, 2026 |
| Barclays | Tim Long | $129 | $125.88 | +1.0% | Jul 29, 2026 |
| Oppenheimer | Martin Yang | $230 | $194.77 | +80.1% | Jul 7, 2026 |
| UBS | Analyst unavailable | $243 | $196.7 | +90.2% | Jul 6, 2026 |
| Mizuho Securities | John Roberts | $270 | $255.54 | +111.4% | Jul 1, 2026 |
| Truist Financial | Matthew Niknam | $205 | $195 | +60.5% | Jun 22, 2026 |
| UBS | Joshua Spector | $228 | $197.93 | +78.5% | Jun 5, 2026 |
| Mizuho Securities | Analyst unavailable | $220 | $207.3 | +72.2% | May 12, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $192.7 | +40.9% | May 8, 2026 |
| Barclays | Tim Long | $180 | $182.42 | +40.9% | May 8, 2026 |
| UBS | Analyst unavailable | $223 | $181.57 | +74.6% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $149 | $149.3 | +16.6% | Apr 29, 2026 |
| Susquehanna | Analyst unavailable | $180 | $153.05 | +40.9% | Apr 29, 2026 |
| Barclays | Tim Long | $149 | $153.05 | +16.6% | Apr 29, 2026 |
| Morgan Stanley | Meta Marshall | $140 | $164.37 | +9.6% | Apr 20, 2026 |
| Mizuho Securities | Analyst unavailable | $160 | $165.1 | +25.3% | Apr 8, 2026 |
| Morgan Stanley | Analyst unavailable | $127 | $139.51 | -0.6% | Feb 23, 2026 |
| Mizuho Securities | Analyst unavailable | $145 | $139.51 | +13.5% | Feb 23, 2026 |
| HSBC | Stephen Bersey | $135 | $131.5 | +5.7% | Feb 13, 2026 |
| UBS | Joshua Spector | $125 | $105.58 | -2.1% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $100.86 | -19.4% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $102.76 | -6.1% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $125 | $104.29 | -2.1% | Jan 29, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $104.29 | -6.1% | Jan 29, 2026 |
| Barclays | Analyst unavailable | $100 | $104.29 | -21.7% | Jan 29, 2026 |
| Wolfe Research | George Notter | $130 | $110.98 | +1.8% | Jan 27, 2026 |
| Morgan Stanley | Meta Marshall | $98 | $86.29 | -23.3% | Dec 17, 2025 |
| UBS | Analyst unavailable | $109 | $78.03 | -14.7% | Nov 21, 2025 |
| Argus Research | Analyst unavailable | $110 | $91.56 | -13.9% | Oct 29, 2025 |
| UBS | Analyst unavailable | $100 | $87.5 | -21.7% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $82 | $87.5 | -35.8% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $97 | $86.43 | -24.1% | Oct 29, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $87.5 | -21.7% | Oct 29, 2025 |
| Susquehanna | Analyst unavailable | $100 | $90.01 | -21.7% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $83 | $86.43 | -35.0% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $75 | $87.19 | -41.3% | Oct 10, 2025 |
| Mizuho Securities | Analyst unavailable | $90 | $82.52 | -29.5% | Oct 3, 2025 |
| UBS | Joshua Spector | $91 | $79.16 | -28.8% | Sep 23, 2025 |
| UBS | Analyst unavailable | $84 | $68.47 | -34.2% | Sep 2, 2025 |
| Mizuho Securities | John Roberts | $74 | $65.77 | -42.1% | Aug 8, 2025 |
| Morgan Stanley | Analyst unavailable | $56 | $62.61 | -56.2% | Jul 30, 2025 |
| Oppenheimer | Analyst unavailable | $72 | $62.61 | -43.6% | Jul 30, 2025 |
| Susquehanna | Analyst unavailable | $75 | $62.61 | -41.3% | Jul 30, 2025 |
| Mizuho Securities | John Roberts | $59 | $53.04 | -53.8% | Jul 15, 2025 |
| Mizuho Securities | John Roberts | $52 | $42 | -59.3% | Apr 15, 2025 |
| HSBC | Stephen Bersey | $60 | $49.8 | -53.0% | Jan 30, 2025 |
| Oppenheimer | Martin Yang | $58 | $48.84 | -54.6% | Oct 30, 2024 |
| Deutsche Bank | Matt Niknam | $54 | $49.03 | -57.7% | Oct 30, 2024 |
| Barclays | Tim Long | $53 | $49.03 | -58.5% | Oct 29, 2024 |
| Bank of America Securities | Wamsi Mohan | $56 | $49.03 | -56.2% | Oct 29, 2024 |
| Deutsche Bank | Matt Niknam | $49 | $45.66 | -61.6% | Oct 9, 2024 |
| Mizuho Securities | John Roberts | $51 | $44.65 | -60.1% | Sep 24, 2024 |
| Bank of America Securities | Wamsi Mohan | $51 | $44.3 | -60.1% | Sep 20, 2024 |
| Susquehanna | Mehdi Hosseini | $55 | $44.33 | -56.9% | Sep 20, 2024 |
| Oppenheimer | Martin Yang | $51 | $44.43 | -60.1% | Sep 20, 2024 |
| Citigroup | Asiya Merchant | $50 | $41.37 | -60.9% | Sep 6, 2024 |
| Mizuho Securities | John Roberts | $47 | $40.73 | -63.2% | Aug 21, 2024 |
| Bank of America Securities | Wamsi Mohan | $46 | $39.74 | -64.0% | Jul 31, 2024 |
| Deutsche Bank | Matt Niknam | $46 | $39.74 | -64.0% | Jul 31, 2024 |
| Morgan Stanley | Meta Marshall | $39 | $42.9 | -69.5% | Jul 26, 2024 |
| Argus Research | Jim Kelleher | $50 | $43.05 | -60.9% | Jul 9, 2024 |
| Mizuho Securities | John Roberts | $42 | $38.75 | -67.1% | Jun 18, 2024 |
| US Capital Advisors | Steve Fox | $45 | $37.25 | -64.8% | Jun 17, 2024 |
| Morgan Stanley | Meta Marshall | $38 | $38.02 | -70.3% | Jun 13, 2024 |
| UBS | Joshua Spector | $38 | $35.55 | -70.3% | May 30, 2024 |
| Mizuho Securities | John Roberts | $36 | $33.44 | -71.8% | May 7, 2024 |
| Susquehanna | Analyst unavailable | $40 | $35.68 | -68.7% | Feb 2, 2023 |
| Susquehanna | Mehdi Hosseini | $50 | $42.12 | -60.9% | Jan 30, 2022 |
| Barclays | Tim Long | $52 | $40.56 | -59.3% | Jan 27, 2022 |
| Oppenheimer | Martin Yang | $48 | $34.93 | -62.4% | Oct 27, 2021 |
Track every rating change on GLW the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.